These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2605353)

  • 1. The effect of moderately severe hemodilution with Fluosol-DA on cytochrome P-450 mediated antipyrine metabolism.
    Shrewsbury RP; Oliver SR; White LG
    Biomater Artif Cells Artif Organs; 1989; 17(4):393-402. PubMed ID: 2605353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of cytochrome P-450 mediated metabolism of antipyrine in the rat at different extents of fluosol-DA hemodilution.
    Shrewsbury RP; White LG
    Res Commun Chem Pathol Pharmacol; 1990 Mar; 67(3):411-4. PubMed ID: 2343186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of moderate fluosol-DA hemodilution on gender specific metabolism of antipyrine.
    Shrewsbury RP; White LG
    Res Commun Chem Pathol Pharmacol; 1989 Jun; 64(3):455-62. PubMed ID: 2781142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of varying percentages of haemodilution with fluosol-DA or normal saline on antipyrine metabolism in the rat.
    Shrewsbury RP; Oliver SR; Anderson WT; Lewis LM; White LG
    J Pharm Pharmacol; 1988 Jun; 40(6):392-8. PubMed ID: 2901469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the method of fluosol-DA administration on antipyrine metabolism in the rat.
    Shrewsbury RP; White LG
    J Pharm Pharmacol; 1990 Nov; 42(11):813-6. PubMed ID: 1982312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Fluosol-DA hemodilution on the kinetics of hepatically eliminated drugs.
    Shrewsbury RP
    Res Commun Chem Pathol Pharmacol; 1987 Mar; 55(3):375-96. PubMed ID: 3575876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute effects of moderate Fluosol-DA hemodilution on hepatic microsomal and nonmicrosomal metabolism in rats.
    Shrewsbury RP
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):1037-43. PubMed ID: 1391424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipyrine kinetics following partial blood exchange with Fluosol-DA in the rat.
    Shrewsbury RP; White SG; Pollack GM; Wargin WA
    J Pharm Pharmacol; 1986 Dec; 38(12):883-7. PubMed ID: 2880960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The in-situ absorption of antipyrine as a measure of intestinal blood flow in Fluosol-DA haemodiluted rats.
    Shrewsbury RP; White LG
    J Pharm Pharmacol; 1990 Jul; 42(7):511-2. PubMed ID: 1980296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of moderate hemodilution with fluosol-DA or normal saline on acetaminophen disposition in the rat.
    Shrewsbury RP; White LG
    Experientia; 1990 Feb; 46(2):213-7. PubMed ID: 2303130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of moderate haemodilution with Fluosol-DA or Hespan on the nonmicrosomal acetylation of sulphadimidine in the rat.
    Shrewsbury RP; Hong DD; White LG; Gordon TR
    J Pharm Pharmacol; 1992 Feb; 44(2):84-8. PubMed ID: 1378493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of moderate haemodilution with Fluosol-DA or normal saline on low-dose phenytoin and (+/-)-5-(4-hydroxyphenyl)-5-phenylhydantoin kinetics.
    Shrewsbury RP; Lewis LM; Oliver SR
    J Pharm Pharmacol; 1987 May; 39(5):349-56. PubMed ID: 2886583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of oxygen-carrying resuscitation fluids on the pharmacokinetics of antipyrine, diazepam, penicillin, and sulfamethazine in rats.
    Kemner JM; Snodgrass WR; Worley SE; Hodges GR; Melethil S; Hignite CE; Tschanz C
    Res Commun Chem Pathol Pharmacol; 1984 Dec; 46(3):381-400. PubMed ID: 6515128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of varying extents of Fluosol-DA or normal saline haemodilution on the dose dependent kinetics of phenytoin in the rat.
    Shrewsbury RP; Oliver SR; Lewis LM; Anderson WT; White LG
    J Pharm Pharmacol; 1989 Aug; 41(8):582-4. PubMed ID: 2571710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of moderate hemodilution with Fluosol on cytochrome P4502D6 activity in the rat.
    Shrewsbury RP; Oliver SR; White LG
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1237-42. PubMed ID: 7849928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of moderate haemodilution with Fluosol-DA or normal saline on indocyanine green and (+)-propranolol kinetics.
    Shrewsbury RP; Lewis LM; Oliver SR; Womble CL
    J Pharm Pharmacol; 1987 Aug; 39(8):592-8. PubMed ID: 2888848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of Fluosol-DA and Hespan haemodilution on S-warfarin elimination in the rat.
    Shrewsbury RP; Hong DD
    J Pharm Pharmacol; 1990 Sep; 42(9):665-6. PubMed ID: 1706766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An experimental study on fluorocarbons as blood substitutes.
    Motta G; Ratto GB; De Barbieri A; Tomellini M; Rovatti M; Sacco A; Castagnola M
    Ital J Surg Sci; 1983; 13(2):89-93. PubMed ID: 6629736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of moderate haemodilution with fluosol-DA or normal saline on ampicillin kinetics in the rat.
    Shrewsbury RP
    J Pharm Pharmacol; 1986 Sep; 38(9):647-52. PubMed ID: 2877063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience with Fluosol-DA (20%) in the United States.
    Tremper KK; Levine EM; Waxman K
    Int Anesthesiol Clin; 1985; 23(1):185-97. PubMed ID: 3884514
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.